Title |
Co-infections and Pathogenesis of KSHV-Associated Malignancies
|
---|---|
Published in |
Frontiers in Microbiology, February 2016
|
DOI | 10.3389/fmicb.2016.00151 |
Pubmed ID | |
Authors |
Suhani Thakker, Subhash C. Verma |
Abstract |
Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpes virus 8 (HHV-8) is one of the several carcinogenic viruses that infect humans. KSHV infection has been implicated in the development of Kaposi's sarcoma (KS), primary effusion lymphoma, and multicentric Castleman's Disease. While KSHV infection is necessary for the development of KSHV associated malignancies, it is not sufficient to induce tumorigenesis. Evidently, other co-factors are essential for the progression of KSHV induced malignancies. One of the most important co-factors, necessary for the progression of KSHV induced tumors, is immune suppression that frequently arises during co-infection with HIV and also by other immune suppressants. In this mini-review, we discuss the roles of co-infection with HIV and other pathogens on KSHV infection and pathogenesis. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 33% |
Switzerland | 1 | 33% |
United States | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 67 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 15 | 22% |
Student > Ph. D. Student | 14 | 21% |
Student > Bachelor | 6 | 9% |
Researcher | 5 | 7% |
Student > Doctoral Student | 3 | 4% |
Other | 6 | 9% |
Unknown | 18 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 15 | 22% |
Immunology and Microbiology | 10 | 15% |
Medicine and Dentistry | 8 | 12% |
Agricultural and Biological Sciences | 6 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Other | 6 | 9% |
Unknown | 19 | 28% |